AllTurio personnel has over 20 years in providing technical and scientific due diligence for in- and out-licensing pharmaceutical and biotech programs, ensuring maximizing their value:

• CMC, nonclinical and clinical assessment of the development program for pipeline projects
• Regulatory compliance with the respective territory
• Quality aspects, including facilities and GMP compliance
• Personnel evaluation – R&D teams and all other relevant departments
• High level IP assessment

Our report will include:

• Position of the targeted therapeutic in the indication/field including an overview of competitive therapies
• Merit of the scientific and clinical rationale
• CMC and pre-clinical data assessment
• Clinical development status and risks
• Regulatory status and correspondence
• Supply assessment and third party vendors